These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17762443)

  • 1. The potential role of Calcitonin Gene-Related Peptide (CGRP) in breast carcinogenesis and its correlation with 99mTc-(V)DMSA scintimammography.
    Papantoniou V; Tsiouris S; Sotiropoulou M; Valsamaki P; Koutsikos J; Ptohis N; Dimitrakakis C; Sotiropoulou E; Melissinou M; Nakopoulou L; Antsaklis A; Zerva C
    Am J Clin Oncol; 2007 Aug; 30(4):420-7. PubMed ID: 17762443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia.
    Papantoniou V; Valsamaki P; Sotiropoulou E; Tsaroucha A; Tsiouris S; Sotiropoulou M; Marinopoulos S; Kounadi E; Karianos T; Fothiadaki A; Archontaki A; Syrgiannis K; Ptohis N; Makris N; Limouris G; Antsaklis A
    Mol Imaging; 2011 Oct; 10(5):370-6. PubMed ID: 21521552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
    Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
    Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
    Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
    Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA.
    Papantoniou V; Sotiropoulou M; Stipsaneli E; Louvrou A; Feda H; Christodoulidou J; Pampouras G; Zerva C; Keramopoulos A; Michalas S
    Clin Nucl Med; 2000 Jun; 25(6):434-9. PubMed ID: 10836691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
    Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent bilateral mammary fibromatosis (desmoid tumor) imaged with technetium-99m pentavalent dimercaptosuccinic acid [99mTc-(V)DMSA] scintimammography.
    Papantoniou V; Koutsikos J; Sotiropoulou M; Feida E; Tsiouris S
    Gynecol Oncol; 2005 Jun; 97(3):964-9. PubMed ID: 15896828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy.
    Papantoniou V; Tsiouris S; Koutsikos J; Sotiropoulou M; Mainta E; Lazaris D; Valsamaki P; Melissinou M; Zerva C; Antsaklis A
    Nucl Med Commun; 2006 Nov; 27(11):911-7. PubMed ID: 17021432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
    Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
    J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen induces reduction of the proliferation-seeking radiotracer 99mTc-(V)DMSA uptake in severe epithelial breast hyperplasia without atypia.
    Papantoniou V; Tsaroucha A; Valsamaki P; Tsiouris S; Sotiropoulou E; Karianos T; Marinopoulos S; Fothiadaki A; Sotiropoulou M; Archontaki A; Syrgiannis K; Dimitrakakis K; Antsaklis A
    Mol Imaging; 2010 Oct; 9(5):233-6. PubMed ID: 20868624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
    Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
    Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
    Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
    Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
    Hirano T; Otake H; Kazama K; Wakabayashi K; Zama A; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.
    Del Vecchio S; Zannetti A; Ciarmiello A; Aloj L; Caracò C; Fonti R; Botti G; D'Aiuto G; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):809-14. PubMed ID: 12029556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications.
    Fondrinier E; Muratet JP; Anglade E; Fauvet R; Berger V; Lorimier G; Jallet P
    Breast; 2004 Aug; 13(4):316-20. PubMed ID: 15325666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.